Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

Cancer Research

Volumn 67, Issue 6, 2007, Pages 2456-2468

  Gaur, Arti ^a   Jewell, David A ^a   Liang, Yu ^b   Ridzon, Dana ^b   Moore, Jason H ^a   Chen, Caifu ^b   Ambros, Victor R ^a   Israel, Mark A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b APPLIED BIOSYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ARTICLE; BIOLOGICAL ACTIVITY; BLOOD DISEASE; CANCER CELL CULTURE; CANCER GENETICS; CARCINOGENESIS; CELL LEVEL; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; COLON TUMOR; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MELANOMA; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; NEOPLASMS; ONCOGENES; UP-REGULATION;

EID: 34047270440     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2698     Document Type: Article

References (50)

1. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5.
2. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004;5:396-400.
3. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-8.
4. Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 2006;17:189-202.
5. McManus MT. MicroRNAs and cancer. Semin Cancer Biol 2003;13:253-8.
6. Caldas C, Brenton JD. Sizing up miRNAs as cancer genes. Nat Med 2005;11:712-4.
7. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8.
8. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122:6-7.
9. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9.
10. Nairz K, Rottig C, Rintelen F, Zdobnov E, Moser M, Hafen E. Overgrowth caused by misexpression of a microRNA with dispensable wild-type function. Dev Biol 2006;291:314-24.
11. Tagawa H, Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 2005;19:2013-6.
12. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-33.
13. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(μ)-miR155 transgenic mice. Proc Natl Acad Sci U S A 2006;103:7024-9.
14. Kluiver J, Haralambieva E, de Jong D, et al. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 2006;45:147-53.
15. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91.
16. Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32.
17. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70.
18. Ciafre SA Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005;334:1351-8.
19. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005;65:6029-33.
20. O'Donnell KA, Wentzel EA Zeller H, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-43.
21. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47.
22. Scherf U, Ross DT, Waltham M, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000;24:236-44.
23. Jirapech-Umpai T, Aitken S. Feature selection and classification for microarray data analysis: evolutionary methods for identifying predictive genes. BMC Bioinformatics 2005;6:148.
24. Wang X, Wang X. Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucleic Acids Res 2006;34: 1646-52.
25. Garraway LA, Sellers WR. From integrated genomics to tumor lineage dependency. Cancer Res 2006;66: 2506-8.
26. Covell DG, Wallqvist A, Huang R, Thanki N, Rabow AA, Lu XJ. Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases. Proteins 2005;59:403-33.
27. Huang R, Wallqvist A, Covell DG. Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action. J Med Chem 2006;49:1964-79.
28. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:e179.
29. Suzuki R, Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 2006;22:1540-2.
30. Liang Y, Diehn M, Watson N, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 2005;102:5814-9.
31. Couzin J. Cancer biology. A new cancer player takes the stage. Science 2005;310:766-7.
32. Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006;16:4-9.
33. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006;94: 776-80.
34. Voorhoeve PM, le Sage C, Schrier M, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006; 124:1169-81.
35. Cifuentes-Diaz C, Alliel PM, Charbonnier F, et al. Regulated expression of the proteoglycan SPOCK in the neuromuscular system. Mech Dev 2000;94: 277-82.
36. Ladendorff NE, Wu S, Lipsick JS. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb. Oncogene 2001;20:125-32.
37. Chano T, Ikegawa S, Kontani K, Okabe H, Baldini N, Saeki Y. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene 2002;21:1295-8.
38. Wienholds E, Plasterk RH. MicroRNA function in animal development. FEBS Lett 2005;579:5911-22.
39. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005;132:4653-62.
40. Massirer KB, Pasquinelli AE. The evolving role of microRNAs in animal gene expression. Bioessays 2006; 28:449-52.
41. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103: 2257-61.
42. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-45.
43. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific MicroRNAs. Dev Cell 2003;5:351-8.
44. Suh MR, Lee Y, Kim JY, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004; 270:488-98.
45. Darr H, Benvenisty N. Factors involved in self-renewal and pluripotency of embryonic stem cells. Handb Exp Pharmacol 2006;174:1-19.
46. Esquela-Kerscher A, Slack FJ. Oncomirs - micro-RNAs with a role in cancer. Nat Rev Cancer 2006;6: 259-69.
47. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004.
48. Abdel-Fattah R, Xiao A, Bomgardner D, Pease CS, Lopes MB, Hussaini IM. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes. J Pathol 2006;209:15-24.
49. Colin C, Baeza N, Bartoli C, et al. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization. Oncogene 2006;25:2818-26.
50. Hughes-Davies L, Huntsman D, Ruas M, et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003;115:523-35.